findmyKOL

Khayyam Durrani, MD

Basic profile

Ophthalmology

ORCIDNone on fileNPI
RegionFarmington, CT · NortheastSpecialtyOphthalmologyFocusOphthalmology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Khayyam Durrani is an Ophthalmology physician. OpenAlex indexes 40 publications with 619 citations (h-index 12).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
40publications

Distinct works indexed by OpenAlex.

619citations

Total citations across indexed works.

12h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
3companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

263 Farmington Ave
Ophthalmology
Farmington, CT 060306227

Telephone

860-679-3540

Registry record last updated 29 Sept 2022.

View the NPPES registry record

Industry payments

3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Sensory organs

    60%
    Prostaglandin Analog24.1%
    Latanoprost83%Travoprost9%Lumigan8%
    Part D106 patients
    alpha-Adrenergic Agonist12.7%
    Brimonidine Tartrate59%Alphagan P17%Brimonidine Tartrate-Timolol12%Combigan12%
    Part D49 patients

    + 6 more classes in this area

  • Cancer & immunology

    11.7%
    Calcineurin inhibitor11.7%
    Restasis67%Cyclosporine33%
    Part D61 patients
  • Anti-infectives

    11.3%
    Fluoroquinolone Antibacterial7%
    Moxifloxacin100%
    Part D74 patients
    Macrolide2.8%
    Erythromycin100%
    Part D16 patients

    + 1 more class in this area

Where care is delivered (Part B)1.8% facility · 98.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”